📰 Molecular Simulation News

Molecular Simulation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Molecular Simulation. Real-time updates on events, politics, business and more.

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

January 30, 2024

/PRNewswire/ -- DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1....

Xiaomin Zhang Anna Lena Unterweger Fabrizio Giordanetto Johnt Chang Eli Lilly Weijie Sun

Source: prnewswire.com

Hagler Institute Announces Its Largest Class Of New Fellows: 14

September 22, 2022

The Class of 2022-23 includes a Nobel Prize recipient and multiple National Academies-level scholars, plus a distinguished lecturer.

New York United States Zuid Holland City Of United Kingdom Rockefeller University

Source: tamu.edu

Iain Boyd – The Conversation

April 15, 2022

Iain Boyd’s profile on The Conversation

United States Iaind Boyd University Of Southampton Department Of Aerospace Engineering Sciences Scientific Advisory Board Royal Aeronautical Society

Source: theconversation.com

Biosimulation Market 2022 Size, Analysis, Top Players and Future Forecasts to 2028 | In Silico Biosc

March 7, 2022

The first class Biosimulation market report works upon a number of industry and market parameters including latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, strategic analysis, insights and innovation. An explicit marke...

United States United Kingdom Silico Biosciences Nuventra Pharma Sciences Chemistry Development Application Drug Development

Source: pharmiweb.com

Frontiers | Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2

January 28, 2022

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic due to the high transmission and mortality rate of this virus. The world health and economic sectors have been severely affected by this deadly virus, exacerbated by the lack of sufficient efficient vaccines. The design of effective drug candidates and their rapid development is necessary to combat this virus. In this study, we selected 23 antimicrobial peptides from the literature and predicted thei...

Saudi Arabia United States San Diego J Neuroimmune Pharmacol Albiol Matanic Dermatophagoides Pteronyssinus

Source: frontiersin.org